Medicine, not food, may have more to gain from cloning
By Rick Barrett,
Milwaukee Journal Sentinel
| 08. 14. 2010
[Quoting CGS's Pete Shanks]
The cloning of animals may have come from agriculture, but its real promise may be in the lucrative field of medicine rather than as food.
Genetically modified cows and goats can produce proteins in their milk that can be extracted as a drug component. Cloning animals to create living drug factories could lower the costs of medicines used to save lives.
Examples include cows that pump pharmaceutical proteins and antibodies in their milk and blood; chickens that lay drug-producing eggs; and pigs that grow human-ready organs. Making perfect copies of these animals, through cloning, could speed up the drug-making process, according to scientists.
"Once you create a genetically engineered animal, you want to make copies," said David Andrews, director of animal biotechnology at the Biotechnology Industry Organization, a trade association that represents 1,200 companies.
In Dane County, a now-closed biotech firm created cloned pigs that had human-friendly, transplantable organs.
The same firm, Infigen, created a herd of cloned cows with drug-making capabilities.
Infigen wanted to produce proteins for the treatment of hemophilia, an affliction that causes uncontrolled bleeding, and Pompe's...
Related Articles
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
Mike Pennington / Dolly the sheep, National
Museums of Scotland, Edinburgh / CC BY-SA 2.0
The first mammal cloned from an adult cell, Dolly the sheep, was born on July 5, 1996. She became a global star, but neither she nor British embryologist Ian Wilmut (her foster daddy) got rich, though Wilmut did eventually receive a knighthood for leading the successful team. Dolly lived a pampered life and died in 2003; her body remains on display at the National Museum...
By David Coltman, Carson Mitchell, Liam Alastair Wayde Carter, and Tommy Galfano, The Conversation | 05.12.2025
Gray wolf by Jessica Eirich via Unsplash
“I’m not a scarcity guy, I’m an abundance guy”
– Colossal co-founder and CEO Ben Lamm, The New Yorker, 4/14/25
Even the most casual consumers of news will have seen the run of recent headlines featuring the company Colossal Biosciences. On March 4, they announced with great fanfare the world’s first-ever woolly mice, as a first step toward creating a woolly mammoth. Then they topped that on April 7 by unveiling one...